Efficacy of intraperitoneally administered paclitaxel for colorectal cancer with peritoneal metastases.
Koji MuronoHiroaki NozawaHiroshi NagataKazuhiro IshimaruHirofumi SonodaShigenobu EmotoManabu KanekoKazuhito SasakiKensuke OtaniKazushige KawaiKei MuroSoichiro IshiharaPublished in: International journal of colorectal disease (2020)
The ip administration of PTX with systemic chemotherapy can potentially control peritoneal metastases in colorectal cancer.